BMS’ Opdivo shows long-term survival benefit

12th September 2019 Uncategorised 0

Opdivo-treated patients continued to experience long-term overall survival benefits compared to docetaxel.

More: BMS’ Opdivo shows long-term survival benefit
Source: News